Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Prescription Dermatological Medications market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Prescription Dermatological Medications market. Detailed analysis of key players, along with key growth strategies adopted by Prescription Dermatological Medications industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Novartis
Almirall
Pfizer
Bristol-Myers Squibb
PharmaDerm
Galderma
Bausch Health
Barrier Therapeutics
Mylan Pharmaceuticals
By Type:
Oral
Topical
By End-User:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Prescription Dermatological Medications Market
-
1.3 Market Segment by Type
-
1.3.1 China Prescription Dermatological Medications Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 China Prescription Dermatological Medications Market Size and Growth Rate of Topical from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Prescription Dermatological Medications Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Prescription Dermatological Medications Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.4.3 China Prescription Dermatological Medications Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Prescription Dermatological Medications Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Prescription Dermatological Medications by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Topical
4 Segmentation of Prescription Dermatological Medications Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Prescription Dermatological Medications by Major End-Users
-
4.4.1 Market Size and Growth Rate of Prescription Dermatological Medications in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Prescription Dermatological Medications in Online Pharmacies
-
4.4.3 Market Size and Growth Rate of Prescription Dermatological Medications in Retail Pharmacies
5 Market Analysis by Regions
-
5.1 China Prescription Dermatological Medications Production Analysis by Regions
-
5.2 China Prescription Dermatological Medications Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Prescription Dermatological Medications Landscape Analysis
-
6.1 North China Prescription Dermatological Medications Landscape Analysis by Major Types
-
6.2 North China Prescription Dermatological Medications Landscape Analysis by Major End-Users
7 Central China Prescription Dermatological Medications Landscape Analysis
-
7.1 Central China Prescription Dermatological Medications Landscape Analysis by Major Types
-
7.2 Central China Prescription Dermatological Medications Landscape Analysis by Major End-Users
8 South China Prescription Dermatological Medications Landscape Analysis
-
8.1 South China Prescription Dermatological Medications Landscape Analysis by Major Types
-
8.2 South China Prescription Dermatological Medications Landscape Analysis by Major End-Users
9 East China Prescription Dermatological Medications Landscape Analysis
-
9.1 East China Prescription Dermatological Medications Landscape Analysis by Major Types
-
9.2 East China Prescription Dermatological Medications Landscape Analysis by Major End-Users
10 Northeast China Prescription Dermatological Medications Landscape Analysis
-
10.1 Northeast China Prescription Dermatological Medications Landscape Analysis by Major Types
-
10.2 Northeast China Prescription Dermatological Medications Landscape Analysis by Major End-Users
11 Southwest China Prescription Dermatological Medications Landscape Analysis
-
11.1 Southwest China Prescription Dermatological Medications Landscape Analysis by Major Types
-
11.2 Southwest China Prescription Dermatological Medications Landscape Analysis by Major End-Users
12 Northwest China Prescription Dermatological Medications Landscape Analysis
-
12.1 Northwest China Prescription Dermatological Medications Landscape Analysis by Major Types
-
12.2 Northwest China Prescription Dermatological Medications Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Novartis
-
13.1.1 Novartis Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Almirall
-
13.2.1 Almirall Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer
-
13.3.1 Pfizer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Bristol-Myers Squibb
-
13.4.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 PharmaDerm
-
13.5.1 PharmaDerm Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Galderma
-
13.6.1 Galderma Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Bausch Health
-
13.7.1 Bausch Health Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Barrier Therapeutics
-
13.8.1 Barrier Therapeutics Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Mylan Pharmaceuticals
-
13.9.1 Mylan Pharmaceuticals Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Prescription Dermatological Medications Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Prescription Dermatological Medications Market Size and Growth Rate of Topical from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Prescription Dermatological Medications Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Prescription Dermatological Medications Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure China Prescription Dermatological Medications Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Prescription Dermatological Medications Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Prescription Dermatological Medications Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Prescription Dermatological Medications
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Prescription Dermatological Medications by Different Types from 2016 to 2027
-
Table Consumption Share of Prescription Dermatological Medications by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Topical
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Prescription Dermatological Medications by Different End-Users from 2016 to 2027
-
Table Consumption Share of Prescription Dermatological Medications by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Table China Prescription Dermatological Medications Production by Regions
-
Table China Prescription Dermatological Medications Production Share by Regions
-
Figure China Prescription Dermatological Medications Production Share by Regions in 2016
-
Figure China Prescription Dermatological Medications Production Share by Regions in 2021
-
Figure China Prescription Dermatological Medications Production Share by Regions in 2027
-
Table China Prescription Dermatological Medications Consumption by Regions
-
Table China Prescription Dermatological Medications Consumption Share by Regions
-
Figure China Prescription Dermatological Medications Consumption Share by Regions in 2016
-
Figure China Prescription Dermatological Medications Consumption Share by Regions in 2021
-
Figure China Prescription Dermatological Medications Consumption Share by Regions in 2027
-
Table North China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table North China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure North China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure North China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure North China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table North China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table North China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure North China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure North China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure North China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table Central China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table Central China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure Central China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure Central China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure Central China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table Central China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table Central China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure Central China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure Central China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table South China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table South China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure South China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure South China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure South China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table South China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table South China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure South China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure South China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure South China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table East China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table East China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure East China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure East China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure East China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table East China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table East China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure East China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure East China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure East China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table Northeast China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table Northeast China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table Northeast China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table Northeast China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure Northeast China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table Southwest China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table Southwest China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table Southwest China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table Southwest China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure Southwest China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table Northwest China Prescription Dermatological Medications Consumption by Types from 2016 to 2027
-
Table Northwest China Prescription Dermatological Medications Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by Types in 2016
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by Types in 2021
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by Types in 2027
-
Table Northwest China Prescription Dermatological Medications Consumption by End-Users from 2016 to 2027
-
Table Northwest China Prescription Dermatological Medications Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by End-Users in 2016
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by End-Users in 2021
-
Figure Northwest China Prescription Dermatological Medications Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
Table Company Profile and Development Status of Almirall
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Almirall
-
Figure Sales and Growth Rate Analysis of Almirall
-
Figure Revenue and Market Share Analysis of Almirall
-
Table Product and Service Introduction of Almirall
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of PharmaDerm
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmaDerm
-
Figure Sales and Growth Rate Analysis of PharmaDerm
-
Figure Revenue and Market Share Analysis of PharmaDerm
-
Table Product and Service Introduction of PharmaDerm
-
Table Company Profile and Development Status of Galderma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma
-
Figure Sales and Growth Rate Analysis of Galderma
-
Figure Revenue and Market Share Analysis of Galderma
-
Table Product and Service Introduction of Galderma
-
Table Company Profile and Development Status of Bausch Health
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bausch Health
-
Figure Sales and Growth Rate Analysis of Bausch Health
-
Figure Revenue and Market Share Analysis of Bausch Health
-
Table Product and Service Introduction of Bausch Health
-
Table Company Profile and Development Status of Barrier Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Barrier Therapeutics
-
Figure Sales and Growth Rate Analysis of Barrier Therapeutics
-
Figure Revenue and Market Share Analysis of Barrier Therapeutics
-
Table Product and Service Introduction of Barrier Therapeutics
-
Table Company Profile and Development Status of Mylan Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals
-
Table Product and Service Introduction of Mylan Pharmaceuticals
-
